Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

GHRP-2 Acetate Oral Taste: Formulation Comparison

Researchers often question whether GHRP-2 acetate oral taste is inherent to the peptide or a function of the salt form and formulation choices made during synthesis. The comparison below contrasts GHRP-2 acetate against alternative counterion formulations and

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Researchers often question whether GHRP-2 acetate oral taste is inherent to the peptide or a function of the salt form and formulation choices made during synthesis. The comparison below contrasts GHRP-2 acetate against alternative counterion formulations and related growth hormone secretagogues to isolate the variables driving taste perception.
  • GHRP-2 Acetate
  • Bitter, metallic, astringent
  • 15–30 seconds
  • Acetate buffer maintains pH 4.5–5.5; oxidation-sensitive
  • Standard research formulation; taste intensity directly correlates with storage compliance
  • GHRP-2 Chloride
  • Mild bitter, neutral
  • 20–40 seconds
  • Chloride is pH-neutral; less buffering capacity but fewer acidic notes
  • Milder taste but less stable during lyophilisation; uncommon in commercial supply
  • GHRP-6 Acetate
  • Bitter, slightly sweet
  • 10–20 seconds
  • Histidine residue adds sweetness; acetate contribution identical to GHRP-2
  • Faster mucosal absorption; sweetness partially masks bitterness
  • Ipamorelin Acetate
  • Faint bitter, minimal metallic
  • 30–45 seconds
  • Most stable of GH secretagogues; minimal oxidation under standard storage
  • Preferred for taste-sensitive applications; higher cost per mg
  • Hexarelin Acetate
  • Strong bitter, persistent
  • 10–15 seconds
  • Rapid mucosal absorption amplifies taste perception; oxidation-prone
  • Most intense taste profile among GHRPs; desensitisation occurs after repeated exposure
  • CJC-1295 (No DAC)
  • Moderate bitter, faint sour
  • 25–35 seconds
  • DAC-free version more stable; acetate buffer standard
  • Longer half-life reduces dosing frequency; taste comparable to GHRP-2 acetate
  • The acetate counterion is consistent across most growth hormone-releasing peptides because it provides superior pH buffering during lyophilisation compared to chloride, sulfate, or phosphate alternatives. However, this buffering benefit comes at the cost of acidity-driven taste amplification. Researchers prioritising sensory neutrality may opt for ipamorelin acetate, which exhibits 40–50% lower bitterness scores in blinded sensory testing while maintaining comparable GH secretagogue activity through the ghrelin receptor pathway.